ABILEAP Trademark
Trademark Overview
On Friday, July 19, 2024, a trademark application was filed for ABILEAP with the United States Patent and Trademark Office. The USPTO has given the ABILEAP trademark a serial number of 98657918. The federal status of this trademark filing is RESPONSE AFTER NON-FINAL ACTION - ENTERED as of Friday, May 2, 2025. This trademark is owned by ABILITY BIOLOGICS INC. The ABILEAP trademark is filed in the Chemical Products, Pharmaceutical Products, and Computer & Software Services & Scientific Services categories with the following description:
Antibody products and molecules, namely, antibodies acting as immune modulators for medical purposes; colostral antibodies for medical purposes; pharmaceutical antibodies for medical use in the treatment of hereditary angioedema (HAE); pharmaceutical antibodies for medical use in the treatment of respiratory diseases and respiratory syndromes; pharmaceutical antibody preparations for the treatment of auto-immune diseases; pharmaceutical antibody preparations for the prevention and treatment of auto-immune diseases; pharmaceutical antibody preparations for the treatment of cancer; pharmaceutical preparations for human use, namely, pharmaceutical antibodies for the treatment of cancer, respiratory diseases, auto-immune diseases, and for the prevention and treatment of solid organ transplant rejection; pharmaceutical preparations for human use, namely, pharmaceutical antibodies for use as anti-infectives, and for use as anti-inflammatories; antibody products, namely, antibody reagents use...
Antibody products and molecules, namely, antibody reagents used for the detection of antigens in cells and tissue for scientific purposes; antibody products and molecules, namely, antibodies acting as immune modulators for scientific purposes
Antibody profiling for scientific research purposes and for discovery and development of new biotherapeutics; providing an online scientific database and website featuring information about medical and scientific research in the fields of cancer, immunology, inflammation, biologics, antibodies and molecules; molecule development, namely, pharmaceutical drug development services; scientific research in the field of conducting clinical trials for others; providing temporary use of a non-downloadable software for managing information in the fields of cancer, immunology, inflammation, biologics, antibodies and molecules; Platform as a service [PaaS] featuring a computer software for analyzing molecular and clinical data to develop antibodies against immune targets; chemical analysis in the field of molecular biology; biotherapeutic research services, namely, molecular analysis and product optimization for the purpose of pharmaceutical development
General Information
| Serial Number | 98657918 |
| Word Mark | ABILEAP |
| Filing Date | Friday, July 19, 2024 |
| Status | 661 - RESPONSE AFTER NON-FINAL ACTION - ENTERED |
| Status Date | Friday, May 2, 2025 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | NOT AVAILABLE |
Trademark Statements
| Goods and Services | Antibody products and molecules, namely, antibodies acting as immune modulators for medical purposes; colostral antibodies for medical purposes; pharmaceutical antibodies for medical use in the treatment of hereditary angioedema (HAE); pharmaceutical antibodies for medical use in the treatment of respiratory diseases and respiratory syndromes; pharmaceutical antibody preparations for the treatment of auto-immune diseases; pharmaceutical antibody preparations for the prevention and treatment of auto-immune diseases; pharmaceutical antibody preparations for the treatment of cancer; pharmaceutical preparations for human use, namely, pharmaceutical antibodies for the treatment of cancer, respiratory diseases, auto-immune diseases, and for the prevention and treatment of solid organ transplant rejection; pharmaceutical preparations for human use, namely, pharmaceutical antibodies for use as anti-infectives, and for use as anti-inflammatories; antibody products, namely, antibody reagents used for the detection of antigens in cells and tissue, for medical purposes |
| Goods and Services | Antibody products and molecules, namely, antibody reagents used for the detection of antigens in cells and tissue for scientific purposes; antibody products and molecules, namely, antibodies acting as immune modulators for scientific purposes |
| Goods and Services | Antibody profiling for scientific research purposes and for discovery and development of new biotherapeutics; providing an online scientific database and website featuring information about medical and scientific research in the fields of cancer, immunology, inflammation, biologics, antibodies and molecules; molecule development, namely, pharmaceutical drug development services; scientific research in the field of conducting clinical trials for others; providing temporary use of a non-downloadable software for managing information in the fields of cancer, immunology, inflammation, biologics, antibodies and molecules; Platform as a service [PaaS] featuring a computer software for analyzing molecular and clinical data to develop antibodies against immune targets; chemical analysis in the field of molecular biology; biotherapeutic research services, namely, molecular analysis and product optimization for the purpose of pharmaceutical development |
Classification Information
| International Class | 001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry. |
| US Class Codes | 001, 005, 006, 010, 026, 046 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, July 19, 2024 |
| Primary Code | 001 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, July 19, 2024 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, July 19, 2024 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
Trademark Owner History
| Party Name | ABILITY BIOLOGICS INC |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Montreal, Quebec H3B2E3
CA |
Trademark Events
| Event Date | Event Description |
| Friday, July 19, 2024 | NEW APPLICATION ENTERED |
| Wednesday, January 15, 2025 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Wednesday, February 5, 2025 | NON-FINAL ACTION E-MAILED |
| Wednesday, January 29, 2025 | ASSIGNED TO EXAMINER |
| Wednesday, February 5, 2025 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Wednesday, February 5, 2025 | NON-FINAL ACTION WRITTEN |
| Friday, May 2, 2025 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Friday, May 2, 2025 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Friday, May 2, 2025 | TEAS/EMAIL CORRESPONDENCE ENTERED |
